Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001595888-25-000074
Filing Date
2025-02-14
Accepted
2025-02-14 17:09:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 6186
  Complete submission text file 0001595888-25-000074.txt   8084
Mailing Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE 2ND FLOOR NEW YORK NY 10022 (646) 293-2100
SEELOS THERAPEUTICS, INC. (Subject) CIK: 0001017491 (see all company filings)

EIN.: 870449967 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-53409 | Film No.: 25630782
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 250 VESEY STREET 6TH FLOOR NEW YORK NY 10281
Business Address 250 VESEY STREET 6TH FLOOR NEW YORK NY 10281 212-651-6069
JANE STREET GROUP, LLC (Filed by) CIK: 0001595888 (see all company filings)

EIN.: 901010033 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G